{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:39:29Z","timestamp":1787935169304,"version":"build-2784847793"},"reference-count":230,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpx.2026.100548","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:21:01Z","timestamp":1777098061000},"page":"100548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nanostructured lipid carriers as co-delivery systems for cancer therapy: Prospects and challenges"],"prefix":"10.1016","volume":"11","author":[{"given":"Aulia Fikri","family":"Hidayat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoga Windhu","family":"Wardhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwendar","family":"Suwendar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Fouad Abdelwahab","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrul","family":"Wathoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100548_bb0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/02652048.2021.2021307","article-title":"The tiny big world of solid lipid nanoparticles and nanostructured lipid carriers: an updated review","volume":"39","author":"Abdel-Mageed","year":"2022","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpx.2026.100548_bb0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41388-026-03733-9","article-title":"Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment","volume":"45","author":"Adams","year":"2026","journal-title":"Oncogene"},{"key":"10.1016\/j.ijpx.2026.100548_bb0015","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: Implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm89020025","article-title":"Olanzapine loaded nanostructured lipid carriers via high shear homogenization and ultrasonication","volume":"89","author":"Ajiboye","year":"2021","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/nano12152672","article-title":"Recent advances in Nanoparticle-based Co-delivery systems for cancer therapy","author":"Al Bostami","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijpx.2026.100548_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125736","article-title":"Nanostructured lipid carriers in cancer therapy: advances in passive and active targeting strategies","author":"Alkhamach","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: Characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2025.1591119","article-title":"Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation","author":"Amoako","year":"2025","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122027","article-title":"Co-delivery of erlotinib and resveratrol via nanostructured lipid carriers: a synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation","volume":"624","author":"Asadollahi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0050","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/molecules28031449","article-title":"Co-Encapsulation of drugs for topical Application\u2014a review","volume":"28","author":"Ataide","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100548_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejpb.2020.08.015","article-title":"Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment","volume":"155","author":"Basso","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2012.12.021","article-title":"Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier","volume":"166","author":"Beloqui","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb0070","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.2c00033","article-title":"Craft of co-encapsulation in nanomedicine: a struggle to achieve synergy through reciprocity","author":"Bhattacharjee","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0075","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.apsb.2025.03.040","article-title":"Precise nanoscale fabrication technologies, the \u201clast mile\u201d of medicinal development","volume":"15","author":"Bi","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100548_bb0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.actbio.2014.09.020","article-title":"Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA","volume":"11","author":"Bishop","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100548_bb0085","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.2147\/IJN.S429565","article-title":"Dually active Apigenin-Loaded nanostructured lipid carriers for cancer treatment","volume":"18","author":"Bonilla-Vidal","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2024.113573","article-title":"Nanostructured lipid carriers co-encapsulating apigenin and melatonin: an innovative strategy against cancer","volume":"250","author":"Bonilla-Vidal","year":"2025","journal-title":"Mater. Des."},{"key":"10.1016\/j.ijpx.2026.100548_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116678","article-title":"Sclareol is a potent enhancer of doxorubicin: evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer","volume":"232","author":"Borges","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0100","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijpx.2026.100548_bb0105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2147\/DDDT.S198003","article-title":"Lung cancer combination therapy: Doxorubicin and \u03b2-elemene co-loaded, pH-sensitive nanostructured lipid carriers","volume":"13","author":"Cao","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijpx.2026.100548_bb0110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2421061122","article-title":"Sequential drug release system: Targeting the tumor ECM for enhanced chemotherapy efficacy","volume":"122","author":"Cao","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpx.2026.100548_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpx.2026.100548_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174400","article-title":"Quercetin and piperine enriched nanostructured lipid carriers (NLCs) to improve apoptosis in oral squamous cellular carcinoma (FaDu cells) with improved biodistribution profile","volume":"909","author":"Chaudhari","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070926","article-title":"Combinatorial delivery of docetaxel- and Erlotinib-Loaded functionalized nanostructured lipid carriers for the treatment of Triple-negative breast cancer using Quality-by-Design approach","volume":"16","author":"Chaudhuri","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2020.07.025","article-title":"The preparation of lipid-based drug delivery system using melt extrusion","author":"Chauhan","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpx.2026.100548_bb0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34172\/apb.2020.021","article-title":"Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery","volume":"10","author":"Chauhan","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ijpx.2026.100548_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135123","article-title":"Development of fucoidan\/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles with machine learning and DoE-ANN implementation: Optimization, characterization, and in-vitro assessment for the anticancer drug delivery","volume":"279","author":"Chaurawal","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0145","doi-asserted-by":"crossref","first-page":"25087","DOI":"10.1021\/acsami.6b07425","article-title":"Oral nanostructured lipid carriers loaded with Near-infrared dye for Image-Guided photothermal therapy","volume":"8","author":"Chen","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100548_bb0150","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3109\/10717544.2015.1038857","article-title":"Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy","volume":"23","author":"Chen","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0155","first-page":"1","article-title":"The role of immune checkpoint inhibitors in cancer therapy: mechanism and therapeutic advances","volume":"6","author":"Chen","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ijpx.2026.100548_bb0160","article-title":"Research progress on the mechanism and intervention strategies of MET protein in regulating the resistance to targeted therapy for EGFR-mutated non-small cell lung cancer","volume":"1\u201320","author":"Chen","year":"2026","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ijpx.2026.100548_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2024.100567","article-title":"Integrated network pharmacology, bioinformatics, and experimental approach to explore the mechanism of honokiol liposomes against glioblastoma","volume":"14","author":"Cheng","year":"2025","journal-title":"Pharmacological Res. Modern Chin. Med."},{"key":"10.1016\/j.ijpx.2026.100548_bb0170","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpx.2026.100548_bb0175","series-title":"Preclinical versus Clinical Drug Combination Studies","author":"Chou","year":"2008"},{"key":"10.1016\/j.ijpx.2026.100548_bb0180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the chou-talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0185","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0190","doi-asserted-by":"crossref","first-page":"13274","DOI":"10.3390\/ijms241713274","article-title":"Hepatocellular carcinoma: past and present challenges and progress in molecular classification and precision oncology","volume":"24","author":"Coffin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0195","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.3748\/wjg.v22.i34.7645","article-title":"Challenges of advanced hepatocellular carcinoma","volume":"22","author":"Colagrande","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0200","first-page":"1","article-title":"Pancreatic neuroendocrine tumors: from benchside to surgical treatment","volume":"62","author":"Conzo","year":"2026","journal-title":"Medicina (B. Aires)."},{"key":"10.1016\/j.ijpx.2026.100548_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124788","article-title":"Doxorubicin and 4-nitrochalcone loaded in beeswax-based nanostructured lipid carriers: in vitro antitumoral screening and evaluation of synergistic effect on HepG-2 cells","volume":"666","author":"Cordeiro","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13679-026-00700-z","article-title":"Why is colorectal cancer occurring earlier? Metabolic dysfunction, underrecognized carcinogens, and emerging controversies","volume":"15","author":"Dalamaga","year":"2026","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.ijpx.2026.100548_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0220","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.2147\/IJN.S413680","article-title":"Subcellular Organelle-Targeted nanostructured lipid carriers for the treatment of metastatic breast cancer","volume":"18","author":"Dang","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clim.2006.06.006","article-title":"The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0230","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"de Almeida","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijpx.2026.100548_bb0235","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.5c00689","article-title":"Codelivery of paclitaxel and cannabidiol in lipid nanoparticles enhances cytotoxicity against melanoma cells","author":"de Carvalho","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijpx.2026.100548_bb0240","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1080\/03639045.2016.1190743","article-title":"Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy","volume":"42","author":"Di","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0245","first-page":"444","article-title":"Size, shape, charge and \u201cstealthy\u201d surface: carrier properties affect the drug circulation time in vivo","volume":"16","author":"Di","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0250","doi-asserted-by":"crossref","first-page":"35086","DOI":"10.1039\/C7RA06119F","article-title":"Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancer","volume":"7","author":"Ding","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0255","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3109\/10717544.2015.1099058","article-title":"Which one performs better for targeted lung cancer combination therapy: Pre- or post-bombesin-decorated nanostructured lipid carriers?","volume":"23","author":"Du","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0260","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.2147\/DDDT.S386100","article-title":"Dual-Drug nanosystem: Etoposide prodrug and cisplatin coloaded nanostructured lipid carriers for lung cancer therapy","volume":"16","author":"Du","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijpx.2026.100548_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43939-025-00489-z","article-title":"Biocompatible nanoparticles in medicine: from design to clinical translation","volume":"6","author":"El-Sayed Ellakwa","year":"2025","journal-title":"Discov. Mater."},{"key":"10.1016\/j.ijpx.2026.100548_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ma16155364","article-title":"Enhanced codelivery of gefitinib and azacitidine for treatment of Metastatic-Resistant lung cancer using biodegradable lipid nanoparticles","volume":"16","author":"Elzayat","year":"2023","journal-title":"Materials"},{"key":"10.1016\/j.ijpx.2026.100548_bb0275","series-title":"Reflection Paper on the Data Requirements for Intravenous Liposomal Products Developed with Reference to an Innovator Liposomal Product","author":"EMA","year":"2013"},{"key":"10.1016\/j.ijpx.2026.100548_bb0280","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1208\/s12249-018-1199-5","article-title":"Augmentation of fluvastatin cytotoxicity against prostate carcinoma PC3 cell line utilizing alpha lipoic\u2013ellagic acid nanostructured lipid carrier formula","volume":"19","author":"Fahmy","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100548_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100905","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance","author":"Fan","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijpx.2026.100548_bb0290","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1007\/s10853-024-09481-z","article-title":"Engineering of smart nanostructured lipid carriers encapsulated in gold nanocomposites and camptothecin for synergistic photothermal and chemotherapy treatment of ovarian cancer","volume":"59","author":"Fan","year":"2024","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0295","series-title":"Liposome drug products chemistry, manufacturing, and controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation Guidance for Industry","author":"FDA","year":"2018"},{"key":"10.1016\/j.ijpx.2026.100548_bb0300","series-title":"Drug products, Including Biological Products, that Contain Nanomaterials Guidance for Industry Contains Nonbinding Recommendations","author":"FDA","year":"2022"},{"key":"10.1016\/j.ijpx.2026.100548_bb0305","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11307-017-1133-3","article-title":"Nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid as a theranostic agent: evaluation of biodistribution and antitumor activity in experimental model","volume":"20","author":"Fernandes","year":"2018","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0310","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.nantod.2015.07.002","article-title":"Electrostatic interactions favor the binding of positive nanoparticles on cells: a reductive theory","volume":"10","author":"Forest","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.ijpx.2026.100548_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-018-1122-7","article-title":"From hype to reality: Data science enabling personalized medicine","volume":"16","author":"Fr\u00f6hlich","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.ijpx.2026.100548_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125549","article-title":"Polymer-lipid hybrid microcarriers for oral codelivery of paclitaxel and tributyrin: development, optimization, and cytotoxicity in cells and spheroids of colorectal cancer","volume":"676","author":"Fukumori","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0325","first-page":"463","article-title":"Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy","volume":"4","author":"Gabizon","year":"2021","journal-title":"Cancer Drug Resistance"},{"key":"10.1016\/j.ijpx.2026.100548_bb0330","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/IJN.S156930","article-title":"Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system","volume":"13","author":"Gagliardi","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0335","article-title":"Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochimica et biophysica acta (BBA) - reviews on","volume":"1873","author":"Gala","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijpx.2026.100548_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814041","article-title":"Lyophilization of nanoparticles, does it really work? Overview of the current status and challenges","volume":"24","author":"Gatto","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0345","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtm.2022.03.009","article-title":"A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery","volume":"25","author":"Gerhardt","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ijpx.2026.100548_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/s41585-019-0193-3","article-title":"A New Era: artificial intelligence and machine learning in prostate cancer","author":"Goldenberg","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2021.05.003","article-title":"Methods for preparation of nanostructured lipid carriers","volume":"199","author":"Gomaa","year":"2022","journal-title":"Methods"},{"key":"10.1016\/j.ijpx.2026.100548_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.70010","article-title":"Nano approaches to nucleic acid delivery: barriers, solutions, and current landscape","volume":"17","author":"Gonzalez","year":"2025","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0365","first-page":"1","article-title":"In vitro release behavior of SLN, NLC, and NE: an explanation based on the particle structure and carried molecule location","volume":"76","author":"Gordillo-Galeano","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/pr10061174","article-title":"Process analytical technology for the production of parenteral lipid emulsions according to good manufacturing practices","author":"Grumbach","year":"2022","journal-title":"Processes"},{"key":"10.1016\/j.ijpx.2026.100548_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109225","article-title":"Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin","volume":"118","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100548_bb0380","article-title":"Co-delivery of exemestane and thymoquinone via nanostructured lipid carriers for efficient breast cancer therapy","volume":"88","author":"Gupta","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0385","article-title":"Machine learning approaches for drug combination therapies","volume":"22","author":"G\u00fcven\u00e7 Paltun","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ijpx.2026.100548_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030288","article-title":"Nanostructured lipid carriers for delivery of chemotherapeutics: a review","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0395","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.procbio.2019.06.013","article-title":"Arginyl-glycyl-aspartic acid (RGD) containing nanostructured lipid carrier co-loaded with doxorubicin and sildenafil citrate enhanced anti-cancer effects and overcomes drug resistance","volume":"84","author":"Hajipour","year":"2019","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijpx.2026.100548_bb0400","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-021-01939-6","article-title":"Emerging Multi-Drug eutectics: Opportunities and challenges","author":"Haneef","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100548_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122580","article-title":"Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer","volume":"632","author":"Hasan","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0410","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1021\/acs.molpharmaceut.5b00992","article-title":"Effects of the microparticle shape on cellular uptake","volume":"13","author":"He","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0415","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.2147\/IJN.S534137","article-title":"A review on QbD-Driven optimization of lipid nanoparticles for oral drug delivery: from framework to formulation","volume":"20","author":"Hidayat","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202200611","article-title":"Nanocarriers with multiple cargo Load\u2014a comprehensive preparation guideline using orthogonal strategies","volume":"44","author":"Hueppe","year":"2023","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.ijpx.2026.100548_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051319","article-title":"Nanostructured lipid carrier Co-Loaded with docetaxel and magnetic nanoparticles: Physicochemical characterization and in vitro evaluation","volume":"15","author":"Idris","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119705","article-title":"Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer","volume":"587","author":"Imran","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0435","series-title":"International Conference on Harmonisation (2003) ICH Guideline on Stability Testing of New Drug Substances and Products Q1A (R2)","year":"2003"},{"key":"10.1016\/j.ijpx.2026.100548_bb0440","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2021.04.007","article-title":"Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: Delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis","volume":"163","author":"Iqubal","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0445","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4314\/tjpr.v22i10.2","article-title":"Co-delivery of combretastatin a4 and docetaxel with pegylated nanostructured lipid carriers in tumor cells","volume":"22","author":"Jia","year":"2023","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0450","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1080\/10717544.2016.1217954","article-title":"Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors","volume":"23","author":"Jiang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0455","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/pharmaceutics16010131","article-title":"Chemistry and art of developing lipid nanoparticles for biologics delivery: Focus on development and Scale-up","volume":"16","author":"John","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0460","first-page":"1","article-title":"Size-Dependent EPR effect of polymeric nanoparticles on tumor targeting","volume":"9","author":"Kang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2026.100548_bb0465","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2230-973X.167661","article-title":"Nanostructured lipid carriers: an emerging platform for improving oral bioavailability of lipophilic drugs","volume":"5","author":"Khan","year":"2015","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ijpx.2026.100548_bb0470","doi-asserted-by":"crossref","first-page":"446","DOI":"10.34172\/apb.2023.056","article-title":"An overview of nanostructured lipid carriers and its application in drug delivery through different routes","volume":"13","author":"Khan","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ijpx.2026.100548_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ijpx.2026.100548_bb0480","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100548_bb0485","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1039\/D4PM00207E","article-title":"Optimized albendazole-loaded nanostructured lipid carrier gel: a redefined approach for localized skin cancer treatment","volume":"1","author":"Khot","year":"2024","journal-title":"RSC Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100548_bb0490","article-title":"Functionalized lipid nanocarriers for simultaneous delivery of docetaxel and tariquidar to chemoresistant cancer cells","volume":"16","author":"Kim","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpx.2026.100548_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124835","article-title":"Fabrication and evaluation of chitosan-coated nanostructured lipid carriers for co-delivery of paclitaxel and PD-L1 siRNA","volume":"666","author":"Kim","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0500","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0505","article-title":"Dual drug loaded nanostructured lipid carrier for cytotoxic effect against breast cancer - a drug repurposing approach","volume":"40","author":"Kumari","year":"2023","journal-title":"Surf. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100548_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111114","article-title":"Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: effects on human breast cancer cells","volume":"134","author":"Lanna","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100548_bb0515","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.actbio.2017.01.070","article-title":"Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy","volume":"53","author":"Li","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100548_bb0520","article-title":"Nanosystem trends in drug delivery using quality-by-design concept","author":"Li","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb0525","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.2147\/IJN.S163929","article-title":"Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0535","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2022.2094498","article-title":"Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review","author":"Li","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0540","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.2147\/IJN.S480799","article-title":"Application of carbon nanomaterials to enhancing tumor immunotherapy: current advances and prospects","volume":"19","author":"Li","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0545","doi-asserted-by":"crossref","DOI":"10.1186\/s40580-025-00502-4","article-title":"Machine learning techniques for lipid nanoparticle formulation","author":"Li","year":"2025","journal-title":"Nano Converg."},{"key":"10.1016\/j.ijpx.2026.100548_bb0550","first-page":"1","article-title":"Research progress on Nano-Drug delivery systems for photothermal cancer therapy","volume":"21","author":"Li","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0555","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2147\/IJN.S121262","article-title":"Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer","volume":"12","author":"Liang","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100548_bb0560","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2147\/IJN.S226249","article-title":"A NAG-Guided Nano-delivery system for redox- and pH-triggered intracellularly sequential drug release in cancer cells","volume":"15","author":"Liang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102597","article-title":"Nano-photosensitizers for enhanced photodynamic therapy","volume":"36","author":"Lin","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.ijpx.2026.100548_bb0570","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3109\/10717544.2015.1031295","article-title":"Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy","volume":"23","author":"Liu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2017.03.017","article-title":"Combinatorial chemistry in drug discovery","author":"Liu","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1412-8","article-title":"Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0585","first-page":"1","article-title":"Stimulus-Responsive nanomedicines for disease diagnosis and treatment","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0590","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/10717544.2022.2027573","article-title":"Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers","volume":"29","author":"Liu","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0595","first-page":"1","article-title":"Exploring treatment options in cancer: Tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2026.100548_bb0600","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/IJN.S35648","article-title":"Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion","volume":"8","author":"Loo","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0605","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/03639045.2016.1226337","article-title":"Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy","volume":"43","author":"Lu","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.111746","article-title":"Optimization of high pressure homogenization conditions to produce nanostructured lipid carriers using natural and synthetic emulsifiers","volume":"160","author":"Luisa L\u00fcdtke","year":"2022","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ijpx.2026.100548_bb0615","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s12672-025-03070-5","article-title":"MRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities","volume":"16","author":"Lv","year":"2025","journal-title":"Disc. Oncol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0620","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-020-00681-8","article-title":"Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality","volume":"18","author":"Ma","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050600","article-title":"Enhanced anticancer efficacy of dual drug-loaded self-assembled nanostructured lipid carriers mediated by ph-responsive folic acid and human-derived cell penetrating peptide dnp2","volume":"13","author":"Ma","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0630","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.apsb.2024.11.012","article-title":"Size-transformable nanotherapeutics for cancer therapy","volume":"15","author":"Ma","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100548_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112464","article-title":"Photodynamic therapy with the dual-mode association of IR780 to PEG-PLA nanocapsules and the effects on human breast cancer cells","volume":"145","author":"Machado","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100548_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071063","article-title":"Multifunctional lipid-based nanoparticles for codelivery of anticancer drugs and sirna for treatment of non-small cell lung cancer with different level of resistance and egfr mutations","volume":"13","author":"Majumder","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0645","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ipha.2024.09.005","article-title":"Nanostructured lipid carriers as a drug delivery system: a comprehensive review with therapeutic applications","volume":"3","author":"Mall","year":"2025","journal-title":"Intell. Pharmacy"},{"key":"10.1016\/j.ijpx.2026.100548_bb0650","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/10837450.2013.867445","article-title":"Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement","volume":"20","author":"Mandpe","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu16060800","article-title":"Healthy lifestyle and cancer risk: modifiable risk factors to prevent cancer","volume":"16","author":"Marino","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ijpx.2026.100548_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117672","article-title":"Nanometrics goes beyond the size: Assessment of nanoparticle concentration and encapsulation efficiency in nanocarriers","volume":"174","author":"Marques","year":"2024","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ijpx.2026.100548_bb0665","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13346-024-01603-z","article-title":"Engineering mannose-functionalized nanostructured lipid carriers by sequential design using hybrid artificial intelligence tools","volume":"15","author":"Martinez-Borrajo","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0670","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/pharmaceutics14091861","article-title":"Plasmid DNA for therapeutic applications in cancer","volume":"14","author":"Mart\u00ednez-Puente","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114054","article-title":"An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity","volume":"385","author":"McClary","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb0680","doi-asserted-by":"crossref","first-page":"22390","DOI":"10.1038\/srep22390","article-title":"Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo","volume":"6","author":"Meng","year":"2016","journal-title":"Scientific Rep."},{"key":"10.1016\/j.ijpx.2026.100548_bb0685","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2018.1504768","article-title":"Quality by design (QbD) approaches in current pharmaceutical set-up","author":"Mishra","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101056","article-title":"Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?","volume":"14","author":"Mollaei","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0695","article-title":"Continuous production of raloxifene hydrochloride loaded nanostructured lipid carriers using hot-melt extrusion technology","volume":"65","author":"Muhindo","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0700","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2008.127","article-title":"Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers","volume":"16","author":"Muro","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100548_bb0705","doi-asserted-by":"crossref","first-page":"30008","DOI":"10.1039\/C7RA01736G","article-title":"Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers","volume":"7","author":"Naderinezhad","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpx.2026.100548_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103959","article-title":"Nanomaterials-assisted photothermal therapy for breast cancer: state-of-the-art advances and future perspectives","author":"Nag","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.ijpx.2026.100548_bb0715","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/nn400223a","article-title":"PH-responsive assembly of gold nanoparticles and \u201cspatiotemporally concerted\u201d drug release for synergistic cancer therapy","volume":"7","author":"Nam","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100548_bb0720","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/mp5007213","article-title":"Micelle-like nanoparticles as carriers for DNA and siRNA","volume":"12","author":"Navarro","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0725","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/IJN.S120685","article-title":"Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers","volume":"12","author":"Ni","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2023.131763","article-title":"Trojan-like doxorubicin and gold nanoparticle entrapped smart nanostructured lipid carriers for breast cancer synergistic chemo\/photothermal therapy","volume":"672","author":"Okuyucu","year":"2023","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ijpx.2026.100548_bb0735","doi-asserted-by":"crossref","DOI":"10.1021\/acsabm.4c01675","article-title":"Chemosensitizer loaded NIR-responsive nanostructured lipid carriers: a tool for drug-resistant breast cancer synergistic therapy","author":"Okuyucu","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijpx.2026.100548_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111255","article-title":"A multifunctional nanomedicine platform for co-delivery of methotrexate and mild hyperthermia towards breast cancer therapy","volume":"116","author":"Ong","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijpx.2026.100548_bb0745","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/pharmaceutics13040531","article-title":"Development of a nanostructured lipid carrier (NLC) by a low-energy method, comparison of release kinetics and molecular dynamics simulation","volume":"13","author":"Ortiz","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0750","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: Synergy opportunities for nanomedicine","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100548_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162628","article-title":"Nanoparticle-based delivery strategies for combating drug resistance in cancer therapeutics","volume":"17","author":"Park","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ijpx.2026.100548_bb0760","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1208\/s12248-014-9674-8","article-title":"Continuous production of fenofibrate solid lipid nanoparticles by Hot-Melt extrusion technology: a systematic study based on a quality by design approach","volume":"17","author":"Patil","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpx.2026.100548_bb0765","article-title":"Designing nucleic acid-based therapeutics for cancer treatment: Updates on the state of the art","volume":"0","author":"Peng","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100548_bb0770","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s42764-020-00009-8","article-title":"Mechanisms of UV-induced mutations and skin cancer","volume":"1","author":"Pfeifer","year":"2020","journal-title":"Genome Instability Dis."},{"key":"10.1016\/j.ijpx.2026.100548_bb0775","doi-asserted-by":"crossref","DOI":"10.1007\/s10103-008-0539-1","article-title":"Photophysics and photochemistry of photodynamic therapy: fundamental aspects","author":"Plaetzer","year":"2009","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2016.06.018","article-title":"Network pharmacology of cancer: from understanding of complex interactomes to the design of multi-target specific therapeutics from nature","author":"Poornima","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0785","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2174\/092986712800099820","article-title":"How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment","volume":"19","author":"Prados","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpx.2026.100548_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2019.04.020","article-title":"Immunological consequences of chemotherapy: single drugs, combination therapies and nanoparticle-based treatments","author":"Pusuluri","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb0795","first-page":"3911","article-title":"Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy","volume":"10","author":"Qu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0800","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1208\/s12249-018-1185-y","article-title":"Nanocarrier-based combination chemotherapy for resistant tumor: Development, characterization, and ex vivo cytotoxicity assessment","volume":"19","author":"Raikwar","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100548_bb0805","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/02652048.2020.1823498","article-title":"Fabrication, optimisation and in vitro evaluation of docetaxel and curcumin co-loaded nanostructured lipid carriers for improved antitumor activity against non-small cell lung carcinoma","volume":"37","author":"Rawal","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpx.2026.100548_bb0810","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s13346-020-00866-6","article-title":"Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer","volume":"11","author":"Rawal","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2022.914126","article-title":"Enzymatic active release of violacein present in nanostructured lipid carrier by lipase encapsulated in 3D-bioprinted Chitosan-Hydroxypropyl methylcellulose matrix with anticancer activity","volume":"10","author":"Rivero Berti","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijpx.2026.100548_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129936","article-title":"Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application","author":"Rizwanullah","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ijpx.2026.100548_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124954","article-title":"Rapamycin-loaded nanostructured lipid carrier modified with folic acid intended for breast cancer therapy","volume":"668","author":"Rodero","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb0830","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00158","article-title":"An introduction to terminology and methodology of chemical synergy-perspectives from across disciplines","author":"Roell","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0835","doi-asserted-by":"crossref","DOI":"10.1007\/s12247-024-09859-1","article-title":"Formulation, optimization and in vitro studies of flutamide-loaded nanostructured lipid carrier based oral drug delivery for enhanced anticancer activity","volume":"19","author":"Sabale","year":"2024","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ijpx.2026.100548_bb0840","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9217268","article-title":"Alpha-mangostin-loaded transferrin-conjugated lipid-polymer hybrid nanoparticles: development and characterization for tumor-targeted delivery","volume":"2022","author":"Sakpakdeejaroen","year":"2022","journal-title":"Sci. World J."},{"key":"10.1016\/j.ijpx.2026.100548_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier","author":"Salvi","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0850","doi-asserted-by":"crossref","first-page":"11671","DOI":"10.1021\/acsomega.3c09098","article-title":"Co-delivery of siRNA and docetaxel to cancer cells by NLC for therapy","volume":"9","author":"\u015eenel","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijpx.2026.100548_bb0855","doi-asserted-by":"crossref","DOI":"10.1007\/s10495-026-02281-7","article-title":"Breast cancer: taxonomy, distribution analysis, risk factors, predictive biomarkers, and modern treatment method","volume":"31","author":"Sengupta","year":"2026","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijpx.2026.100548_bb0860","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcis.2021.08.153","article-title":"Co-loading of doxorubicin and iron oxide nanocubes in polycaprolactone fibers for combining magneto-thermal and chemotherapeutic effects on cancer cells","volume":"607","author":"Serio","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0865","article-title":"Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology","volume":"3","author":"Shadambikar","year":"2021","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.ijpx.2026.100548_bb0870","first-page":"309","article-title":"Fluorescence imaging using indocyanine green dye in the pediatric population","volume":"25","author":"Shafy","year":"2020","journal-title":"J. Pediatric Pharmacol. Therapeut. JPPT"},{"key":"10.1016\/j.ijpx.2026.100548_bb0875","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/IJN.S77837","article-title":"Targeted lung cancer therapy: Preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA","volume":"10","author":"Shao","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb0880","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy\u2014current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ijpx.2026.100548_bb0885","doi-asserted-by":"crossref","DOI":"10.1007\/s10876-024-02714-w","article-title":"Potential of silymarin and metformin Co-Loaded nanostructured lipid carriers containing mucoadhesive thermogel on KB cells of oral cancer","author":"Shete","year":"2024","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0890","article-title":"Near-infrared photothermal\/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress","volume":"7","author":"Shirata","year":"2017","journal-title":"Scientific Rep."},{"key":"10.1016\/j.ijpx.2026.100548_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/app9204438","article-title":"Soft cationic nanoparticles for drug delivery: production and cytotoxicity of solid lipid nanoparticles (SLNs)","volume":"9","author":"Silva","year":"2019","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0900","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","article-title":"Zeta potential: a case study of cationic, anionic, and neutral liposomes","volume":"409","author":"Smith","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijpx.2026.100548_bb0905","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijpx.2026.100548_bb0910","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","author":"Soares","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijpx.2026.100548_bb0915","first-page":"1","article-title":"Towards principled design of cancer nanomedicine to accelerate clinical translation","volume":"13","author":"Souri","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ijpx.2026.100548_bb0920","doi-asserted-by":"crossref","DOI":"10.1007\/s40005-022-00603-w","article-title":"A quality by design approach in oral extended release drug delivery systems: where we are and where we are going?","author":"Sousa","year":"2023","journal-title":"J. Pharm. Investig."},{"issue":"3","key":"10.1016\/j.ijpx.2026.100548_bb0925","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3897\/pharmacia.70.e108119","article-title":"Technological strategies for the preparation of lipid nanoparticles: an updated review","volume":"70","author":"Stefanov","year":"2023","journal-title":"Pharmacia"},{"key":"10.1016\/j.ijpx.2026.100548_bb0930","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-020-04848-0","article-title":"Optimization of nanostructured lipid carriers: Understanding the types, designs, and parameters in the process of formulations","author":"Subramaniam","year":"2020","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0935","article-title":"Better together: Nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy","author":"Sun","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0940","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijpx.2026.100548_bb0945","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.9b05679","article-title":"Overcoming the reticuloendothelial system barrier to drug delivery with a \u201cDon\u2019t-Eat-Us\u201d strategy","author":"Tang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100548_bb0950","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.3390\/ijms252212284","article-title":"Recent advances and prospects in RNA drug development","volume":"25","author":"Tani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb0955","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2013.04.018","article-title":"Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary Co-delivery of anticancer drugs and siRNA","volume":"171","author":"Taratula","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb0960","article-title":"Collagen scaffold-mediated delivery of NLC\/siRNA as wound healing materials","volume":"55","author":"Tezgel","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb0965","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jconrel.2023.05.029","article-title":"Reducing off-target drug accumulation by exploiting a type-III interferon response","volume":"358","author":"Tilden","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb0970","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s11095-010-0170-2","article-title":"Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells","volume":"27","author":"Tompkins","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0975","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/08982104.2020.1720718","article-title":"Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells","volume":"31","author":"Varshosaz","year":"2021","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpx.2026.100548_bb0980","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-022-00420-8","article-title":"Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance","volume":"11","author":"Vasseur","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ijpx.2026.100548_bb0985","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25122874","article-title":"Magnetic hyperthermia for cancer treatment: Main parameters affecting the outcome of in vitro and in vivo studies","author":"Vilas-Boas","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100548_bb0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2024.1296091","article-title":"Lipid-based nanoparticles as drug delivery carriers for cancer therapy","volume":"14","author":"Waheed","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijpx.2026.100548_bb1000","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3109\/10717544.2015.1055619","article-title":"Lung cancer combination therapy: Co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb1005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jsps.2021.06.006","article-title":"Nano lipidic carriers for codelivery of sorafenib and ganoderic acid for enhanced synergistic antitumor efficacy against hepatocellular carcinoma","volume":"29","author":"Wang","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ijpx.2026.100548_bb1010","article-title":"Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies","author":"Wang","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijpx.2026.100548_bb1015","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.2147\/IJN.S478964","article-title":"Advancements and challenges of nanostructured lipid carriers for wound healing applications","volume":"19","author":"Wathoni","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13030303","article-title":"Optimization of tilmicosin-loaded nanostructured lipid carriers using orthogonal design for overcoming oral administration obstacle","volume":"13","author":"Wen","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb1025","doi-asserted-by":"crossref","DOI":"10.1517\/17425247.2016.1165662","article-title":"Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery","author":"Wu","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb1030","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3109\/10717544.2015.1058434","article-title":"Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery","volume":"23","author":"Wu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb1035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.10.011","article-title":"The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system","volume":"552","author":"Xiao","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40092","article-title":"Biological and clinical characteristics of non-small cell lung cancer non-specific subtype","volume":"10","author":"Xie","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijpx.2026.100548_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.102070","article-title":"Magnetic hyperthermia in oncology: nanomaterials-driven combinatorial strategies for synergistic therapeutic gains","author":"Xiong","year":"2025","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.ijpx.2026.100548_bb1050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/10717544.2020.1785581","article-title":"Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect","volume":"27","author":"Xu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb1055","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.7150\/thno.108357","article-title":"TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis","volume":"15","author":"Xu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpx.2026.100548_bb1060","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.apsb.2025.05.039","article-title":"Engineering strategies of sequential drug delivery systems for combination tumor immunotherapy","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100548_bb1065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.canlet.2012.07.002","article-title":"Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer","volume":"334","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpx.2026.100548_bb1070","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/10717544.2016.1236849","article-title":"Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer","volume":"24","author":"Yang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100548_bb1075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121156","article-title":"Recent advances and challenges in controlling the spatiotemporal release of combinatorial anticancer drugs from nanoparticles","author":"Yoon","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100548_bb1080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.partic.2023.11.014","article-title":"Applications of artificial intelligence to lipid nanoparticle delivery","volume":"90","author":"Yuan","year":"2024","journal-title":"Particuology"},{"key":"10.1016\/j.ijpx.2026.100548_bb1085","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ijpx.2026.100548_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103207","article-title":"A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: a systematic review","author":"Zagalo","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100548_bb1095","doi-asserted-by":"crossref","first-page":"28615","DOI":"10.1039\/C4RA02995J","article-title":"In vitro effects of differentially shaped hydroxyapatite microparticles on RAW264.7 cell responses","volume":"4","author":"Zeng","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpx.2026.100548_bb1100","article-title":"Advances in magnetic induction hyperthermia","author":"Zhang","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100548_bb1105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2016.06.012","article-title":"Nanomedicine of synergistic drug combinations for cancer therapy \u2013 strategies and perspectives","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb1110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100548_bb1115","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2147\/IJN.S161163","article-title":"Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy","volume":"13","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpx.2026.100548_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118595","article-title":"Construction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6","volume":"569","author":"Zhang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100548_bb1125","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01628-x","article-title":"The anti-tumor and renoprotection study of E-[c(RGDfK)2]\/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride\/salvianolic acid a","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100548_bb1130","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.apsb.2022.11.026","article-title":"Lipid carriers for mRNA delivery","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100548_bb1135","article-title":"Recent advances in functionalized ferrite nanoparticles: from fundamentals to magnetic hyperthermia cancer therapy","author":"Zhang","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100548_bb1140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","article-title":"Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers","volume":"143","author":"Zhao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100548_bb1145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cjche.2024.07.028","article-title":"Engineering stable multi-component pH responsive nanomedicine for enhanced photothermal\/photodynamic therapy","volume":"81","author":"Zheng","year":"2025","journal-title":"Chin. J. Chem. Eng."},{"key":"10.1016\/j.ijpx.2026.100548_bb1150","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/DDDT.S236997","article-title":"Formulation, preparation and evaluation of nanostructured lipid carrier containing naringin and coix seed oil for anti-tumor application based on \u201cunification of medicines and excipients\u201d","volume":"14","author":"Zhu","year":"2020","journal-title":"Drug Des. Devel. Ther."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259015672600068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259015672600068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:40:11Z","timestamp":1785210011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259015672600068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":230,"alternative-id":["S259015672600068X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100548","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanostructured lipid carriers as co-delivery systems for cancer therapy: Prospects and challenges","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100548"}}